Company Overview
Tactile Systems Technology, Inc. operates within the Healthcare sector specifically targeting the Medical Devices industry by developing and providing specialized medical devices designed to treat underserved chronic diseases in the United States. The company's core product offerings include the Flexitouch Plus system, which functions as a pneumatic compression device utilized for the treatment of conditions such as lymphedema, phlebolymphedema, lipedema, and venous insufficiency. As of the latest data, the entity maintains a market capitalization of $591.49M and employs a workforce of 1,086 individuals to support its operations and product development. These financial figures, combined with an annual revenue of $329.52M, indicate that Tactile Systems Technology, Inc. holds a significant position within the medical technology landscape, reflecting a substantial operational scale and a dedicated focus on addressing specific unmet clinical needs through proprietary hardware solutions.
Financial Health
The company reported a revenue of $329.52M over the trailing twelve months, generating a net income of $19.09M and an EBITDA of $35.92M during the same period. The substantial gap between the $329.52M in revenue and the $19.09M in net income reveals a cost structure where operating expenses, including cost of goods sold, research, and administrative costs, consume a significant portion of top-line revenue before arriving at the bottom line. However, the EBITDA of $35.92M suggests that the core business operations generate robust cash earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of operational profitability excluding capital structure and non-cash items. The free cash flow stands at $34.58M, which indicates a strong capacity for financial flexibility, allowing the company to fund capital expenditures, repay debt, or pursue strategic acquisitions without relying heavily on external financing. Regarding liquidity and leverage, the company holds $83.45M in cash against $15.96M in debt, resulting in a debt-to-equity ratio of 7.29, which suggests a balance sheet that is heavily weighted toward equity rather than debt financing. This conservative leverage position is further supported by a current ratio of 4.03, indicating that the company possesses more than four times the current assets necessary to cover its short-term liabilities, thereby ensuring robust short-term liquidity. Furthermore, the return on equity is recorded at 8.8% and the return on assets at 6.4%, metrics that reveal how effectively management is utilizing shareholder capital and total assets to generate profits, though these returns are moderate compared to high-growth technology peers.
Valuation Assessment
The valuation of Tactile Systems Technology, Inc. is characterized by a trailing P/E ratio of 32.15 and a forward P/E of 17.81, where the significant difference between these two metrics implies that the market expects a substantial increase in earnings growth to justify the current high multiple relative to future projections. The price-to-book ratio is stated at 2.70, which indicates that the stock trades at a market premium of 170% over its net asset book value, suggesting that investors are paying extra for the company's intangible assets, brand, and future growth potential. Alternative valuation metrics further contextualize the stock's price, with a price-to-sales ratio of 1.79 and an EV/EBITDA of 14.43, suggesting that the market values the company based on its sales efficiency and earnings power relative to enterprise value. In terms of trading range, the stock has a 52-week high of $37.77 and a 52-week low of $8.61, meaning the current price sits significantly below the 52-week high while remaining well above the 52-week low, reflecting recent volatility and a recovery from the annual low. The beta value is 0.96, which means the stock's price volatility moves in near-perfect correlation with the broader market, exhibiting slightly less sensitivity to market swings than a beta of 1.00 would suggest.
Growth & Income
The company demonstrated a revenue growth of 21.0% year-over-year alongside an earnings growth of 17.6%, indicating that while earnings are growing, they are doing so at a slightly slower pace than revenue, which may imply that margins are under pressure or that revenue expansion is outpacing the bottom-line realization. As a non-dividend payer, Tactile Systems Technology, Inc. reports a dividend yield of N/A and a payout ratio of 0.0%, which explains that the company chooses to reinvest all of its earnings into research and development, market expansion, or operational improvements rather than distributing cash to shareholders. This strategy of retaining earnings is common for medical device companies seeking to fund innovation in treating chronic diseases without diluting shareholder value through equity issuance. Overall, the growth and income profile reflects a high-growth, no-dividend strategy where capital is prioritized for long-term product innovation and market penetration in the underserved chronic disease sector rather than immediate income generation for investors.